Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VELPATASVIR Cause Hyperbilirubinaemia? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hyperbilirubinaemia have been filed in association with VELPATASVIR. This represents 13.0% of all adverse event reports for VELPATASVIR.

7
Reports of Hyperbilirubinaemia with VELPATASVIR
13.0%
of all VELPATASVIR reports
3
Deaths
0
Hospitalizations

How Dangerous Is Hyperbilirubinaemia From VELPATASVIR?

Of the 7 reports, 3 (42.9%) resulted in death.

Is Hyperbilirubinaemia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VELPATASVIR. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does VELPATASVIR Cause?

Fatigue (15) Anaemia (12) Headache (12) Nausea (10) Treatment failure (10) Hepatitis c (9) Pruritus (9) Insomnia (8) Hepatocellular carcinoma (7) Alanine aminotransferase increased (6)

What Other Drugs Cause Hyperbilirubinaemia?

METHOTREXATE (603) RIBAVIRIN (560) VINCRISTINE (479) CYTARABINE (397) PEGASPARGASE (349) ACETAMINOPHEN (330) CYCLOPHOSPHAMIDE (330) DEXAMETHASONE (315) CAPECITABINE (279) SOFOSBUVIR (260)

Related Pages

VELPATASVIR Full Profile All Hyperbilirubinaemia Reports All Drugs Causing Hyperbilirubinaemia VELPATASVIR Demographics